Dr Reddy’s launches Deferasirox film-covered drugs within the US market

Dr Reddy’s launches Deferasirox film-covered drugs within the US market

by admin- Friday, December 6th, 2019 04:11:24 PM

Dr. Reddy’s Laboratories has introduced the launch of Deferasirox Tablets for Oral Suspension, a therapeutically equivalent common model of Exjade (deferasirox) Tablets for Oral Suspension, permitted by means of the US Food and Drug Administration (USFDA).

The Exjade emblem had US income of about $113 million MAT for the most recent three hundred and sixty five days ending in September 2019 according to IQVIA Health.

Dr. Reddy’s Deferasirox Tablets for Oral Suspension, are to be had in a hundred twenty five mg, 250 mg, and 500 mg dosage strengths in bottle rely sizes of 30.

News Updates